Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.24.1.1.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Revenue:        
Licensing revenues from customers $ 0 $ 54 $ 0 $ 68
Total revenues 0 54 0 68
Operating expenses:        
Royalties and license fees (3) 0 (108) 0
Research and development 2,566 3,167 12,097 9,588
General and administrative 1,578 1,228 4,953 5,011
Total operating expenses 4,141 4,395 16,942 14,599
Loss from operations (4,141) (4,341) (16,942) (14,531)
Other income (loss):        
Foreign currency transaction loss (118) (45) (22) (391)
Interest expense, net (4) (7) (16) (25)
Other income (expense), net (16) 0 (50) 50
Unrealized loss on investment 0 (4) (1) (4)
Total other income (loss), net (138) (56) (89) (370)
Net loss (4,279) (4,397) (17,031) (14,901)
Other comprehensive income (loss):        
Unrealized foreign currency translation gain (loss) 117 45 (5) 392
Total other comprehensive income (loss) 117 45 (5) 392
Total comprehensive loss $ (4,162) $ (4,352) $ (17,036) $ (14,509)
Net loss per share: basic $ (1.64) $ (2.67) $ (6.95) $ (11.47)
Net loss per share: diluted $ (1.64) $ (2.67) $ (6.95) $ (11.47)
Weighted average number of shares outstanding: basic 2,616,288 1,645,951 2,449,295 1,299,423
Weighted average number of shares outstanding: diluted 2,616,288 1,645,951 2,449,295 1,299,423